Product Information

PIOGLITAZONE-METFORMIN 15-850 is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2932 per EA under NDC 57237021860. Its NADAC has been published 506 times since Oct 19, 2016.

PIOGLITAZONE-METFORMIN 15-850

Pioglitazone Hydrochloride and Metformin Hydrochloride
$0.2932per EA

Strength

850; 15 mg/1; mg/1

NDC

57237021860

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA200823

On Market Since

2/13/2013

Pharmacological Classes

Biguanide
Biguanides
Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for PIOGLITAZONE-METFORMIN 15-850 has been published 506 times since Oct 19, 2016, and over the history we have for it it has declined 83.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2932 per EA
All-time high$1.7583 (Nov 16, 2016)
All-time low$0.2180 (May 22, 2024)
52-week high$0.2990
52-week low$0.2441
Median price$0.5787
Average price$0.6126
Largest weekly change-54.8% (Sep 20, 2023)
Weeks tracked506
Tracking sinceOct 19, 2016

Price History

1W

0.0%

1M

+4.2%

3M

+4.1%

6M

-0.1%

1Y

+20.1%

3Y

-21.9%

5Y

-48.1%

All

-83.3%

Generic Alternatives

The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PIOGLITAZONE-METFORMIN 15-850?

The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE-METFORMIN 15-850, manufactured by Rising Pharma Holdings Inc., is $0.2932 per EA (NDC 57237021860), effective Jun 24, 2026.

How has the price of PIOGLITAZONE-METFORMIN 15-850 changed over time?

Over the history we have for it, the NADAC for PIOGLITAZONE-METFORMIN 15-850 has declined 83.3%. It has been tracked across 506 weekly CMS publications since Oct 19, 2016.

What are the highest and lowest recorded NADAC prices for PIOGLITAZONE-METFORMIN 15-850?

Since Oct 19, 2016, the NADAC for PIOGLITAZONE-METFORMIN 15-850 has ranged from a low of $0.2180 (May 22, 2024) to a high of $1.7583 (Nov 16, 2016), with a median of $0.5787 per EA.

Are there cheaper alternatives to PIOGLITAZONE-METFORMIN 15-850?

2 NADAC-published products share the same active ingredient, strength, and dosage form as PIOGLITAZONE-METFORMIN 15-850, but none are currently priced below it.

Who manufactures PIOGLITAZONE-METFORMIN 15-850?

PIOGLITAZONE-METFORMIN 15-850 (NDC 57237021860) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.